Developing nations will soon receive aid in order to fight diseases like measles and rubella. Brazil has taken the initiative to sponsor a new vaccine. This new vaccine will combat both measles and rubella at the same time.
The vaccine will be delivered to developing nations mostly in Africa. The Vaccine will be made by Bio-Manguinhos and supported and funded by the Melinda and Bill Gates Foundation and the Oswaldo Cruz Foundation (Fiocruz,) respectively. The plan was announced at a medical science conference sponsored by the Gates Foundation in Rio de Janeiro.
According to Brazilian health minister Alexandre Padhilha, Brazil is focused on investing and expanding its health sciences program. According to Reuters.com, Brazil is “following other leading emerging nations such as China and India in investing in biomedical technology to supply vaccines and medicines to developing countries at lower costs than those produced by pharmaceutical industries in developed nations.”
Researchers have estimated the vaccine will change health reports of developing nations. According to reports collected by Bio-Manguinos, measles kills around 158,000 people each year. Most measles-related deaths are children under the age of five. In addition, contagious, viral diseases with symptoms similar to those of measles-such as rubella-can cause serious consequences to pregnant women and their babies.
Fortunately, Bio-Manguinos has spearheaded several dual-action vaccine projects. Because of their vast experience, the new vaccine is likely to be a success. Bio-Manguinos plans to produce 30 million doses per year of the new measles/rubella vaccine to supply developing countries in Africa, Asia and Latin America.
In addition, the Gates Foundation will grant $1.1 million to “support clinical trials and additional research.” The innovative vaccine will reach clinical trials within the next two years. It is expected to reach the world market by 2017.
– Stephanie Olaya